Susan M. Kanaya
Keine laufenden Positionen mehr
Profil
Susan M.
Kanaya held several financial positions in the biotech industry, including Treasurer & Vice President-Finance at Sugen, Inc. from 1994 to 1999, Chief Financial Officer & Senior VP-Finance at Kosan Biosciences, Inc. from 1999 to 2005, and Chief Financial Officer, Secretary & Director at ChemoCentryx, Inc. from 2021 to 2022.
Prior to her work in biotech, she was a Controller at KPMG, Inc. and at an unknown firm referred to as "50".
Kanaya received an undergraduate degree from the University of California, Berkeley.
Ehemalige bekannte Positionen von Susan M. Kanaya
| Unternehmen | Position | Ende |
|---|---|---|
| CHEMOCENTRYX, INC. | Director of Finance/CFO | 20.10.2022 |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Director of Finance/CFO | 01.01.2005 |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY. | Treasurer | 01.01.1999 |
KPMG, Inc.
 KPMG, Inc. Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG, Inc. provides audit and accounting services. The private company is based in Vancouver, Canada. The CEO of the Canadian company is Walter R. Pela. | Comptroller/Controller/Auditor | - |
| 50/50 Micro Electronics, Inc. | Comptroller/Controller/Auditor | - |
Ausbildung von Susan M. Kanaya
| University of California, Berkeley | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY. | Health Technology |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
KPMG, Inc.
KPMG, Inc. Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG, Inc. provides audit and accounting services. The private company is based in Vancouver, Canada. The CEO of the Canadian company is Walter R. Pela. | Commercial Services |
| 50/50 Micro Electronics, Inc. |
